Skip to content
Open access

A prognostic nomogram predicts survival in metastatic renal cell carcinoma using SEER data from 2016 to 2022

Sep 2026 · Scientific Reports · 0 citations

TL;DR

A prognostic nomogram is constructed for mRCC patients, providing a proof-of-concept framework for post-treatment risk stratification, prognostic counseling, and individualized follow-up planning and indicates that surgical intervention is significantly associated with superior survival outcomes in selected patients.

Abstract

Research on the prognosis of patients with metastatic renal cell carcinoma (mRCC) in the contemporary period (2016–2022) remains limited. This study aimed to construct a prognostic nomogram for mRCC patients and identify key clinical factors influencing their prognosis. Univariate and multivariate Cox regression analyses were performed to determine independent risk factors, which were subsequently used to construct the prognostic nomogram. The nomogram’s performance was comprehensively assessed using the C-index, area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). The SHapley Additive exPlanations (SHAP) method was applied to rank the importance of features influencing 6-month, 1-year, 2-year, and 3-year overall survival (OS). In addition, propensity score matching (PSM) and Kaplan-Meier survival analysis were conducted to compare survival outcomes between patients who did and did not receive surgery. The nomogram demonstrated acceptable discriminative performance with good calibration, as evidenced by the C‑index, AUC, calibration curves, and DCA. SHAP analysis revealed that surgery was the most important factor at all evaluated time points. Furthermore, after PSM balancing, patients who underwent surgery had a 39% reduction in the risk of death (OS) (HR 0.61; 95% CI 0.49–0.75; p  < 0.001) and a 41% reduction in the risk of cancer‑specific mortality (CSS; HR 0.59; 95% CI 0.48–0.74; p  < 0.001). Subgroup analysis demonstrated that surgery conferred a survival benefit in patients with bone and lung metastases, whereas no significant benefit was observed in those with brain or liver metastases. In conclusion, we constructed a prognostic nomogram for mRCC patients, providing a proof-of-concept framework for post-treatment risk stratification, prognostic counseling, and individualized follow-up planning. Our findings also indicate that surgical intervention is significantly associated with superior survival outcomes in selected patients.

Read PDF

Similar papers

Open access Sep 2026

Analysis of prognostic factors in patients with locally advanced cervical squamous cell carcinoma and development of a nomogram prediction model

A clinical predictive model was established to estimate 3-, 4-, and 5-year survival rates for LACSC patients and exhibited significantly poorer overall survival in both cohorts (P < 0.05).

Ting-Ting Zou, Xu-Peng Wang, Hai-Xia Wu et al. · 0 citations
Open access Sep 2026

Optimizing Clinical Outcomes: A Nomogram for Predicting Gastric Cancer Survival in Elderly Patients Following Gastrectomy

The novel nomogram can conveniently and accurately predict CSS in elderly patients with non-metastatic GC after gastrectomy, which can assist clinicians in adopting individualized treatment strategies to improve the prognosis of elderly patients with GC.

Jun Li, Jiang Zhu, Xu Song et al. · 0 citations
Open access Sep 2026

Mapping significant clinical factors to relapse-free survival prognosis in breast cancer patients

The results show that patients who received chemotherapy demonstrated a shorter median RFS compared to those who did not, and radiotherapy was associated with improved prognosis, in line with meta-analyses showing reduced breast cancer mortality post-radiotherapy.

Boby Al Qurthuby, I. M. Murwantara · 0 citations
Open access Sep 2026

Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma: A Multicentre Cohort Study

Background and Purpose: The Lung Immune Prognostic Index (LIPI), based on derived neutrophil-to-lymphocyte ratio (dNLR) and Lactate Dehydrogenase (LDH), is a recognized biomarker in various malignancies. However, its incremental value over the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) sco...

S. Gokcek, M. Uzun, F. Özalp et al. · 0 citations
Open access Sep 2026

Prognostic stratification and treatment patterns in pancreatic adenocarcinoma with mixed subtypes based on an exploratory retrospective cohort study

Pancreatic adenocarcinoma with mixed subtypes (p‑AMs) is a rare malignancy, and evidence to guide clinical management remains lacking. This study aimed to develop a prognostic model and explore treatment patterns across risk strata. Using the Surveillance, Epidemiology, and End Results (SEER) database, we...

Xuefeng Hua, Hui Gong, Zi-Wei Yin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.